CIBC Asset Management
TMO icon

CIBC Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

CIBC Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108M Sell
214,502
-22,390
-9% -$10.7M 0.24% 83
2026
Q1 		$116M Buy
236,892
+3,299
+1% +$1.79M 0.28% 67
2025
Q4 		$135M Buy
233,593
+7,822
+3% +$4.42M 0.33% 59
2025
Q3 		$109M Sell
225,771
-12,258
-5% -$5.71M 0.32% 58
2025
Q2 		$96M Buy
238,029
+10,609
+5% +$4.44M 0.3% 61
2025
Q1 		$113M Sell
227,420
-5,190
-2% -$2.81M 0.38% 57
2024
Q4 		$121M Sell
232,610
-13,103
-5% -$7.2M 0.4% 54
2024
Q3 		$152M Buy
245,713
+6,313
+3% +$3.74M 0.49% 48
2024
Q2 		$132M Sell
239,400
-8,582
-3% -$4.92M 0.47% 49
2024
Q1 		$144M Sell
247,982
-5,461
-2% -$3.06M 0.5% 45
2023
Q4 		$135M Buy
253,443
+6,297
+3% +$3.05M 0.5% 47
2023
Q3 		$125M Sell
247,146
-4,067
-2% -$2.17M 0.52% 45
2023
Q2 		$131M Buy
251,213
+7,579
+3% +$4.09M 0.5% 48
2023
Q1 		$140M Buy
243,634
+1,433
+0.6% +$808K 0.56% 45
2022
Q4 		$133M Buy
242,201
+2,159
+0.9% +$1.14M 0.56% 41
2022
Q3 		$122M Buy
240,042
+56,794
+31% +$31.8M 0.53% 40
2022
Q2 		$99.6M Buy
183,248
+27,629
+18% +$15.2M 0.4% 48
2022
Q1 		$91.9M Buy
155,619
+16,620
+12% +$9.55M 0.32% 52
2021
Q4 		$92.7M Sell
138,999
-9,144
-6% -$5.71M 0.34% 52
2021
Q3 		$84.6M Sell
148,143
-6,230
-4% -$3.42M 0.34% 54
2021
Q2 		$77.9M Buy
154,373
+14,369
+10% +$6.78M 0.31% 56
2021
Q1 		$63.9M Sell
140,004
-11,159
-7% -$5.33M 0.27% 61
2020
Q4 		$70.4M Sell
151,163
-11,711
-7% -$5.49M 0.33% 55
2020
Q3 		$71.9M Buy
162,874
+38,727
+31% +$16M 0.37% 49
2020
Q2 		$45M Buy
124,147
+18,441
+17% +$6.18M 0.26% 58
2020
Q1 		$30M Buy
105,706
+51,515
+95% +$16.2M 0.21% 71
2019
Q4 		$17.6M Sell
54,191
-3,516
-6% -$1.07M 0.1% 102
2019
Q3 		$16.8M Buy
57,707
+648
+1% +$186K 0.1% 98
2019
Q2 		$16.8M Sell
57,059
-2,247
-4% -$619K 0.1% 94
2019
Q1 		$16.2M Sell
59,306
-82
-0.1% -$20.4K 0.1% 99
2018
Q4 		$13.3M Sell
59,388
-704
-1% -$165K 0.1% 96
2018
Q3 		$14.7M Buy
60,092
+191
+0.3% +$43.9K 0.09% 102
2018
Q2 		$12.4M Sell
59,901
-3,033
-5% -$644K 0.08% 112
2018
Q1 		$13M Sell
62,934
-4,840
-7% -$1.02M 0.08% 104
2017
Q4 		$12.9M Sell
67,774
-9,928
-13% -$1.9M 0.08% 109
2017
Q3 		$14.7M Buy
77,702
+233
+0.3% +$42.2K 0.09% 97
2017
Q2 		$13.5M Sell
77,469
-7,890
-9% -$1.33M 0.09% 97
2017
Q1 		$13.1M Sell
85,359
-1,955
-2% -$299K 0.09% 99
2016
Q4 		$12.3M Sell
87,314
-255
-0.3% -$37.6K 0.09% 101
2016
Q3 		$13.9M Buy
87,569
+519
+0.6% +$80K 0.1% 91
2016
Q2 		$12.9M Buy
87,050
+17,951
+26% +$2.65M 0.1% 100
2016
Q1 		$9.78M Buy
69,099
+2,022
+3% +$271K 0.07% 121
2015
Q4 		$9.52M Sell
67,077
-1,646
-2% -$220K 0.08% 121
2015
Q3 		$8.4M Buy
68,723
+652
+1% +$84.9K 0.07% 124
2015
Q2 		$8.83M Buy
68,071
+6,516
+11% +$849K 0.06% 129
2015
Q1 		$8.27M Sell
61,555
-145
-0.2% -$18.7K 0.06% 136
2014
Q4 		$7.73M Sell
61,700
-10,921
-15% -$1.33M 0.05% 140
2014
Q3 		$8.84M Sell
72,621
-861
-1% -$105K 0.05% 139
2014
Q2 		$8.67M Sell
73,482
-682
-0.9% -$80.3K 0.05% 153
2014
Q1 		$8.92M Buy
74,164
+5,482
+8% +$652K 0.05% 146
2013
Q4 		$7.65M Sell
68,682
-5,351
-7% -$532K 0.05% 160
2013
Q3 		$6.82M Sell
74,033
-100
-0.1% -$9.04K 0.04% 171
2013
Q2 		$6.27M Buy
+74,133
New +$6.17M 0.04% 171

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

CIBC Asset Management's TMO Position: Q2 2026 in Review

CIBC Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 9.5% in Q2 2026, selling an estimated $10.7M and leaving 214,502 shares worth $108M. The position accounts for 0.24% of the portfolio, ranked #83.

CIBC Asset Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $152M in Q3 2024. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • CIBC Asset Management held 214,502 shares of Thermo Fisher Scientific worth $108M as of Q2 2026.
  • CIBC Asset Management sold 22,390 Thermo Fisher Scientific shares in Q2 2026, an estimated $10.7M.
  • Thermo Fisher Scientific made up 0.24% of CIBC Asset Management's portfolio in Q2 2026, its #83 holding.
  • CIBC Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • CIBC Asset Management's Thermo Fisher Scientific position peaked at $152M in Q3 2024.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.